Asia - East

China releases draft regulations from country's Center for Drug Evaluation on Patient-Reported-Outcomes.

China will reform the pricing of medical services provided by public hospitals as part of its campaign to make healthcare more affordable.

A U.S. appeals court threw out a price-fixing lawsuit against two Chinese companies that make vitamin C, a case that spotlighted trade tensions between the United States and China.

In China, Big Pharma companies know all too well that their off-patent drugs face intense pressure from a relatively new price-cutting scheme.

China's spiraling Delta variant outbreak has reached Wuhan, the original epicenter of the pandemic, prompting citywide coronavirus testing as authorities scramble to contain the city's first reported local infections in more than a year.

Sales of the Swiss drug maker's major plaque psoriasis treatment Cosentyx in China quadrupled in the second quarter, despite its price being slashed by more than 60%.

As recently as May, public opinion polls showed that a large majority of Japanese didn't want the Olympics to proceed due to the pandemic.

The origin of the virus remains contested among experts.

The bulk of the first 50 million doses were expected by June, but global demand has slowed that schedule.

China's National Medical Products Administration has okayed use of the drug with chemotherapy in adults with extensive-stage small cell lung cancer (SCLC), the Anglo-Swedish drugmaker said.

The new deals include up to 170 million doses of the Sinopharm shot and up to 380 million shots of the Sinovac vaccine, through to the middle of 2022.

China is currently organizing a second and third batch of national drug centralized procurement, and a total of 87 products have been selected, with an average price reduction of 53 percent.

The move marked a sharp turnabout from as recently as last week, when some officials were still insisting they could organise the Games safely with some fans.

Japan has pledged $1 billion and 30 million doses to the global vaccine sharing scheme COVAX, but so far its donations have been outside of that programme.

Japan’s Supreme Court has upheld lower courts’ not-guilty ruling for a former Novartis Pharma K.K. employee over a research paper based on falsified data on clinical research into hypertension drug Diovan.